"Il campus di Roma dell’Università Cattolica del Sacro Cuore, con la Facoltà di Medicina e Chirurgia e la Facoltà di Economia, garantisce un’offerta formativa all’avanguardia, interdisciplinare e sempre più apprezzata da studenti internazionali. Grazie alla prestigiosa partnership con la Fondazione Policlinico Universitario Agostino Gemelli IRCCS, la sinergia tra didattica, ricerca e assistenza sanitaria costituisce un “laboratorio formativo” unico dove gli studenti possono “sperimentare” le conoscenze acquisite in aula confrontandosi con l’attività clinica e la complessità organizzativa e gestionale. Soluzioni architettoniche moderne offrono un ambiente funzionale e accogliente che favorisce la collaborazione e lo scambio culturale."

During the past decade, Policlinico Gemelli - Università Cattolica del Sacro Cuore conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Policlinico Gemelli - Università Cattolica del Sacro Cuore" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Catholic University of the Sacred Heart" with 2 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Fractyl Laboratories, Inc." with 1 trials sponsored and "Loxo Oncology, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Policlinico Gemelli - Università Cattolica del Sacro Cuore" #1 collaborator was "Canisius-Wilhelmina Hospital" with 1 trials as a collaborator, "Clinical Centre of Serbia" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "National Institute of Infectious Diseases Matei Bals" with 1 trials as a collaborator and "Universiteit Antwerpen" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Policlinico Gemelli - Università Cattolica del Sacro Cuore" are "Ulcerative Colitis" (2 trials), "Bacterial Resistance" (1 trials), "Biliary Stricture" (1 trials), "Breast Neoplasms" (1 trials) and "Cardiac Surgery" (1 trials). Many other conditions were trialed in "Policlinico Gemelli - Università Cattolica del Sacro Cuore" in a lesser frequency.

Most popular intervention types in "Policlinico Gemelli - Università Cattolica del Sacro Cuore" are "Drug" (9 trials), "Device" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Mirikizumab" (3 trials), "Placebo" (3 trials), "Abemaciclib" (2 trials), "Tirzepatide" (2 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Policlinico Gemelli - Università Cattolica del Sacro Cuore" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Policlinico Gemelli - Università Cattolica del Sacro Cuore". undefined are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Policlinico Gemelli - Università Cattolica del Sacro Cuore, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Policlinico Gemelli - Università Cattolica del Sacro Cuore, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".